Article
Twenty-five percent of the population in the United States is under the age of 14. What’s more, one-quarter of these children have some type of visual need.
FDA accepts new drug application for low-dose atropine from Sydnexis
Commercial real estate and your practice, part two with Colin Carr
AI and eye tracking: Technological companions to assess amblyopia in pediatric patients
Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)
Study highlights strong parental cooperation in preschool vision screening
Vyluma announces NMPA of China accepts drug application of NVK002 (low-dose atropine 0.01%) for myopia progression in children